SMH
·general
·4 hours ago
‘Unviable’: 450,000 Australians to miss out on subsidised weight loss drug
Eli Lilly's decision not to subsidise its weight loss drug Mounjaro will leave 450,000 Australians without access to the medication. The Pharmaceutical Benefits Advisory Committee had recommended the drug for Type 2 diabetes patients, highlighting the need for better access to effective treatment options. The outcome may also hinder future subsidies for related conditions.
Summary by Glance · SMH
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI